← Back to all trials
Enrolling By Invitation
NCT07633600
Phenotype Guided Vasoactive Medication During Kidney Transplantation
Conditions: Kidney Transplant, Fluid Management
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 255
Sponsor: Jennifer Cutler
Location: Cedars Sinai Medical Center Los Angeles California
Summary
The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Undergoing kidney transplantation at Cedars-Sinai Medical Center
* Able to provide informed consent
Exclusion Criteria:
* Patients unable to provide informed consent
* Patients with contraindications to protocol vasoactive medications, as determined by the treating anesthesiologist
* Patients in whom required intraoperative monitoring cannot be performed
Source: ClinicalTrials.gov (NCT07633600). StuddyBuddy aggregates publicly available trial information.
